Optimieren Sie Ihre Suche

  • Bücher (24)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

Robert r. nesbitt (24 Ergebnisse)

Autor: 
Mit der Detailsuche verfeinern
  • Sprache: Englisch

    Verlag: Springer, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: Books From California, Simi Valley, CA, USABooks From California

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Sehr gut

    EUR 42,50

    EUR 4,54 Versand 
    Versand innerhalb von USA

    Anzahl: 8 verfügbar

    hardcover. Zustand: Fine.

  • Sprache: Englisch

    Verlag: Springer, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: Books From California, Simi Valley, CA, USABooks From California

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Gut

    EUR 42,50

    EUR 4,54 Versand 
    Versand innerhalb von USA

    Anzahl: 8 verfügbar

    hardcover. Zustand: Very Good.

  • Zustand: Gebraucht - Wie neu

    EUR 18,74

    EUR 8,64 Versand 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    In den Warenkorb

    Zustand: As New. Prompt Shipment, shipped in Boxes, Tracking PROVIDED1.

  • Sprache: Englisch

    Verlag: HARVARD UNIV PR, 1968

    0674453018 / 9780674453012

    • Hardcover
    • Erstausgabe

    Anbieter: Roland Antiquariat UG haftungsbeschränkt, Weinheim, DeutschlandRoland Antiquariat UG haftungsbeschränkt

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht

    EUR 24,90

    EUR 42,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Hardcover. 1st Edition. 388 Seiten Good condition. Reading pages are clean and without marks. Retired library exemplar, with the usual marking. Corners slightly rubbed or bumped. 9780674453012 Sprache: Englisch Gewicht in Gramm: 770.

  • Sprache: Englisch

    Verlag: Springer, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: California Books, Miami, FL, USACalifornia Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 74,02

    EUR 2,73 Versand 
    Versand innerhalb von USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New.

  • Sprache: Englisch

    Verlag: Harvard University Press, 2014

    0674421752 / 9780674421752

    • Hardcover

    Anbieter: Home-set, Mannheim, DeutschlandHome-set

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 48,00

    EUR 49,90 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Gebundene Ausgabe. Zustand: Neu. Neuware, Lieferung aus Deutschland. Sprache: Englisch Gewicht in Gramm: 708.

  • Sprache: Englisch

    Verlag: Springer Nature, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 89,77

    EUR 12,01 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Hardcover. Zustand: Brand New. 149 pages. 9.26x6.11x9.25 inches. In Stock.

  • Sprache: Englisch

    Verlag: Springer, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 67,23

    EUR 35,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form ('pill' or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in 'human-centered design' into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book.…

  • Sprache: Englisch

    Verlag: Springer, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: Home-set, Mannheim, DeutschlandHome-set

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 66,86

    EUR 49,90 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Gebundene Ausgabe. Zustand: Neu. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form ("pill" or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in "human-centered design" into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book. Sprache: Englisch Gewicht in Gramm: 349.…

  • Sprache: Englisch

    Verlag: Springer International Publishing AG, Cham, 2025

    3031982525 / 9783031982521

    • Hardcover

    Anbieter: AussieBookSeller, Truganina, VIC, AustralienAussieBookSeller

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 95,27

    EUR 33,66 Versand 
    Versand von Australien nach USA

    Anzahl: 1 verfügbar

    Hardcover. Zustand: new. Hardcover. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in human-centered design into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Sprache: Englisch

    Verlag: Springer, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 247,93

    EUR 18,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New.

  • Sprache: Englisch

    Verlag: Springer, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Wie neu

    EUR 287,90

    EUR 18,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: As New. Unread book in perfect condition.

  • Sprache: Englisch

    Verlag: Springer, 2020

    3030314146 / 9783030314149

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Hardcover

    Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 285,54

    EUR 22,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. In English.

  • Sprache: Englisch

    Verlag: Springer, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 285,54

    EUR 22,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New. In English.

  • Sprache: Englisch

    Verlag: Springer International Publishing, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: moluna, Greven, Deutschlandmoluna

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 250,30

    EUR 48,99 Versand 
    Versand von Deutschland nach USA

    Anzahl: Mehr als 20 verfügbar

    Kartoniert / Broschiert. Zustand: New.

  • Sprache: Englisch

    Verlag: Springer International Publishing, 2020

    3030314146 / 9783030314149

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Hardcover

    Anbieter: moluna, Greven, Deutschlandmoluna

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 250,30

    EUR 48,99 Versand 
    Versand von Deutschland nach USA

    Anzahl: Mehr als 20 verfügbar

    Gebunden. Zustand: New.

  • Sprache: Englisch

    Verlag: Springer Nature Switzerland AG, CH, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes KönigreichRarewaves.com USA

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 327,86

     Versand gratis 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Paperback. Zustand: New. 2020 ed. The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products.  It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them.  It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device.  Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.…

  • Weitere Bilder

    Sprache: Englisch

    Verlag: Springer, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: preigu, Osnabrück, Deutschlandpreigu

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 256,95

    EUR 70,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 5 verfügbar

    Taschenbuch. Zustand: Neu. Development of Biopharmaceutical Drug-Device Products | Feroz Jameel (u. a.) | Taschenbuch | AAPS Advances in the Pharmaceutical Sciences Series | xviii | Englisch | 2021 | Springer | EAN 9783030314170 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

  • Sprache: Englisch

    Verlag: Springer, 2020

    3030314146 / 9783030314149

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Hardcover

    Anbieter: California Books, Miami, FL, USACalifornia Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 353,24

    EUR 2,73 Versand 
    Versand innerhalb von USA

    Anzahl: Mehr als 20 verfügbar

    Zustand: New.

  • Sprache: Englisch

    Verlag: Springer, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 336,13

    EUR 44,46 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide 'one stop shopping' for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies.With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field. …

  • Sprache: Englisch

    Verlag: Springer Nature Switzerland AG, CH, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: Rarewaves.com UK, London, Vereinigtes KönigreichRarewaves.com UK

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 315,00

    EUR 78,08 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: Mehr als 20 verfügbar

    Paperback. Zustand: New. 2020 ed. The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products.  It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them.  It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device.  Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.…

  • Sprache: Englisch

    Verlag: Palgrave Pivot, 2020

    3030314146 / 9783030314149

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Hardcover

    Anbieter: Home-set, Mannheim, DeutschlandHome-set

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 374,49

    EUR 64,37 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Gebundene Ausgabe. Zustand: Neu. The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field. Sprache: Englisch Gewicht in Gramm: 1462.…

  • Sprache: Englisch

    Verlag: Springer Nature, 2021

    3030314170 / 9783030314170

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Softcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 440,37

    EUR 18,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Paperback. Zustand: Brand New. 911 pages. 9.25x6.10x1.80 inches. In Stock.

  • Sprache: Englisch

    Verlag: Springer, 2020

    3030314146 / 9783030314149

    Serie: Buch 35 von 38 - AAPS Advances in the Pharmaceutical Sciences

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 442,63

    EUR 24,02 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Hardcover. Zustand: Brand New. 911 pages. 9.25x6.10x2.05 inches. In Stock.